title: The protective role of G protein-coupled estrogen receptor 1 (GPER-1) on methotrexate-induced nephrotoxicity in human renal epithelium cells.
abstract: Nephrotoxicity is an important problem during methotrexate (MTX) treatment, which has been widely used for the treatment of several cancer types. Females are less susceptible to kidney diseases; however, the reason for this condition has not to be fully clarified. But sex hormones such as estrogen may have a protective effect on the kidney. We aimed to evaluate the possible protective role of estrogen on the MTX-induced renal epithelial cell death. Primary renal proximal tubular epithelial cells (RPTEC) were incubated with MTX (1, 10 and 100 μM), either alone or in combination with the 17β-estradiol, G protein-coupled estrogen receptor 1 (GPER1) agonist G-1, estrogen receptor alpha agonist propyl pyrazole triol (PPT), estrogen receptor beta agonist diarylpropionitrile (DPN). Cell viability was determined by MTT assays. Interleukin (IL)-1β, IL-6, superoxide dismutase (SOD) and malondialdehyde (MDA) levels were determined in RPTEC. Approximately half of the cell death was observed with 10 μM MTX incubation for 48 h. The cell death was prevented by co-incubating with17β-estradiol, PPT and G-1. MTX was significantly induced IL-1β and IL-6.17β-estradiol, PPT and G-1 significantly decreased effects of MTX. SOD activity was significantly decreased treatment with MTX compared to control group. SOD activity was increased with co-incubation with 17β-estradioland G-1 compared to treatment with MTX. MDA levels significantly increased in treatment with MTX compared with the control group. Increased MDA levels by MTX-induced was decreased significantly by the treatment with 17β-estradiol and G-1. These data indicate that especially 17β-estradiol and G-1 may be useful in preventing undesirable effects of MTX in renal failure.
authors.affiliation: a Department of Pharmacology, Faculty of Medicine , Kahramanmaras Sutcu Imam University , Kahramanmaras , Turkey ;
authors.forename: Akif Hakan
authors.initials: AH
authors.lastname: Kurt
authors.affiliation: b Department of Chest Diseases, Faculty of Medicine , Kahramanmaras Sutcu Imam University , Kahramanmaras , Turkey ;
authors.forename: Fulsen
authors.initials: F
authors.lastname: Bozkus
authors.affiliation: c Department of Biochemistry, Medical Faculty , Kahramanmaras Sutcu Imam University , Kahramanmaras , Turkey.
authors.forename: Nuray
authors.initials: N
authors.lastname: Uremis
authors.affiliation: c Department of Biochemistry, Medical Faculty , Kahramanmaras Sutcu Imam University , Kahramanmaras , Turkey.
authors.forename: Muhammed Mehdi
authors.initials: MM
authors.lastname: Uremis
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D002478:Cells, Cultured; D004847:Epithelial Cells / Q000378:metabolism / Q000473:pathology; D004958:Estradiol / Q000494:pharmacology; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control; D007687:Kidney Tubules, Proximal / Q000378:metabolism / Q000473:pathology; D008727:Methotrexate / Q000009:adverse effects*; D009570:Nitriles / Q000494:pharmacology*; D010636:Phenols / Q000494:pharmacology*; D011422:Propionates / Q000494:pharmacology*; D020011:Protective Agents / Q000378:metabolism / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology*; D011960:Receptors, Estrogen / Q000378:metabolism
chemical_list: C486182:2,3-bis(4-hydroxyphenyl)-propionitrile; D000964:Antimetabolites, Antineoplastic; D009570:Nitriles; D010636:Phenols; D011422:Propionates; D020011:Protective Agents; D011720:Pyrazoles; D011960:Receptors, Estrogen; C486184:4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol; D004958:Estradiol; D008727:Methotrexate
keywords: Estrogen; G protein-coupled estrogen receptor 1; kidney; methotrexate; nephrotoxicity